Examples of using Lymphomas in English and their translations into Romanian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Lymphoid leukemias and lymphomas are now considered to be tumors of the same type of cell lineage.
multiple myeloma, lymphomas….
With the current knowledge, a risk for the development of lymphomas or other malignancies in patients treated with a TNF-blocking agent cannot be excluded(see section 4.8).
psoriasis clinical trials, 18 lymphomas were reported.
Pixuvri is used for the treatment of adult patients with multiply relapsed or refractory aggressive Non-Hodgkin Lymphomas.
The B cell tumours include CLL(generally associated with lower levels of CD20 expression) and non-Hodgkin's lymphomas(where> 90% tumours have high levels of CD20 expression).
the cancer of immune system(lymphomas).
clarify diagnosis of leukemia, lymphomas and myelomas.
leukemia, lymphomas, renal tumours and brain tumours.
Multiple myeloma is the second most frequent form of malignant bone marrow disease and belongs to the non-Hodgkin group of lymphomas.
We have several members with types of lymphoma other than follicular, including CLL, marginal zone, mantle cell, T-cell and aggressive(diffuse) lymphomas.
lymphogranulomatosis and lymphomas should be excluded.
psoriasis clinical trials, 18 lymphomas were reported.
psoriasis clinical trials, 18 lymphomas were reported.
Non-Hodgkin's lymphomas are described as either being aggressive, growing and spreading quickly with severe symptoms,
Non-Hodgkin's malignant lymphomas comprise a heterogeneous group of malignancies of the immune system(except Hodgkin's lymphoma).
In processing complex lymphomas drugs are administered intravenously at high doses, which may require
Malignant lymphomas may occur in patients receiving low-dose methotrexate; in which case, methotrexate must be discontinued.
The reported rates for non-melanoma skin cancers and lymphomas are approximately 0.2
A possible risk for the development of lymphomas or other malignancies in patients treated with a TNF-antagonist cannot be excluded.